APA aipamena

García-Alfonso, P., Muñoz-Martin, A. J., Alvarez-Suarez, S., Jerez-Gilarranz, Y., Riesco-Martinez, M., Khosravi, P., & Martin, M. (2010). Bevacizumab in combination with biweekly capecitabine and irinotecan, as first-line treatment for patients with metastatic colorectal cancer. Nature Publishing Group.

Chicago Style aipamena

García-Alfonso, P., A J. Muñoz-Martin, S. Alvarez-Suarez, Y. Jerez-Gilarranz, M. Riesco-Martinez, P. Khosravi, and M. Martin. Bevacizumab in Combination With Biweekly Capecitabine and Irinotecan, As First-line Treatment for Patients With Metastatic Colorectal Cancer. Nature Publishing Group, 2010.

MLA aipamena

García-Alfonso, P., et al. Bevacizumab in Combination With Biweekly Capecitabine and Irinotecan, As First-line Treatment for Patients With Metastatic Colorectal Cancer. Nature Publishing Group, 2010.